SILVERBACK THERAPEUTICS INC (SBTX) Stock Analyst Ratings
USA - NASDAQ:SBTX - US82835W1080 - Common Stock
5.87 USD
+0.06 (+1.03%)
ChartMill assigns a Buy % Consensus number of 43% to SBTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is -13.12% below the current price.
SBTX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about SBTX.
In the previous month the buy percentage consensus was at a similar level.
SBTX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-12 | SVB Leerink | Maintains | Outperform |
| 2021-08-16 | SVB Leerink | Maintains | Outperform |
| 2021-05-27 | JonesTrading | Initiate | Buy |
| 2021-05-17 | SVB Leerink | Maintains | Outperform |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
| 2021-03-30 | Stifel | Maintains | Buy |
SILVERBACK THERAPEUTICS INC / SBTX FAQ
What is the price target for SBTX stock?
6 analysts have analysed SBTX and the average price target is 5.1 USD. This implies a price decrease of -13.12% is expected in the next year compared to the current price of 5.87.
Can you provide the consensus rating for SILVERBACK THERAPEUTICS INC stock?
The consensus rating for SILVERBACK THERAPEUTICS INC (SBTX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for SILVERBACK THERAPEUTICS INC stock?
The number of analysts covering SILVERBACK THERAPEUTICS INC (SBTX) is 6.